For laboratory research use only. Not for human consumption.
Free U.S. shipping on $200+GLPZone / The research collection
Illustrative certificateNS-2026-06065Nordicstar Analytical Sciences
Thymalin 10 MG
Immunology
Thymic peptide preparation & cellular differentiation
A pair saves 10%. A set of three saves 15%.
For laboratory research use only.
Not for human consumption or clinical use.
The records shown here are illustrative. Request laboratory-issued documentation for your lot before ordering.
Priority, tracked shipping within the United States, free on orders of $200 or more after savings. Add Priority dispatch at checkout to have your order packed first; Private Clients receive it on every order. Follow the product documentation for laboratory handling requirements.
Shipping information01 / The compound
Thymic peptide preparation & cellular differentiation
Thymalin is a thymus-derived polypeptide preparation composed of multiple peptide components rather than one defined peptide molecule. Published research describes natural thymic peptides isolated from calf thymus and reports the isolation of the dipeptide EW (Glu-Trp) from Thymalin.
Later research has examined additional short peptide components associated with the Thymalin preparation, including KE and EDP.
Thymalin should not be confused with Thymulin, a distinct defined zinc-dependent thymic nonapeptide, or with Thymogen, the synthetic Glu-Trp dipeptide developed from research involving the EW component identified in Thymalin.
02 / Research profile
Thymalin: A thymus-derived polypeptide preparation containing multiple peptide components.
Thymulin: A distinct defined thymic nonapeptide whose biological activity is associated with zinc binding. Thymalin and Thymulin are different research entities and the names should not be used interchangeably.
Published laboratory research using human hematopoietic stem cells examined Thymalin-associated changes in markers involved in cellular differentiation, including CD44, CD117 and CD28. These findings provide experimental context for Thymalin-related cellular research and should not be interpreted as evidence of a clinical treatment effect.
Research has examined short peptide components associated with the Thymalin preparation, including EW, KE and EDP. Experimental studies have investigated gene regulation, protein expression and other molecular pathways associated with these peptides. Findings involving an isolated component should not automatically be attributed to the complete Thymalin preparation.
Published in-vitro work has examined Thymalin and related short peptides in experimentally stimulated human peripheral blood mononuclear cells and other laboratory systems. Reported measurements have included inflammatory signaling markers and cytokine release. These are mechanistic laboratory findings and should not be presented as established human clinical outcomes. Research context: Published Thymalin research spans different experimental models and study designs. Findings from the scientific literature describe Thymalin or its studied components and do not establish effects of GLPZone material.
Reading the evidence
The cited findings describe the compound in the experimental systems used. Cellular, biochemical and animal results should be interpreted according to their model, methods and endpoints; they do not establish the performance of a GLPZone lot.
03 / Reference data
Reference specifications describe a compound. The final lot documentation identifies the material supplied.
| Compound | Thymalin |
|---|---|
| Research area | Immunology |
| Physical form | Lyophilized |
| Vial options | 10 MG |
| Intended use | Laboratory research only |
Variant amounts are nominal catalog quantities. They are not instructions for use.
HPLC separates components under a defined method. Read the reported percentage alongside the chromatogram, wavelength, integration method, and scope of the test.
Mass spectrometry provides molecular-mass evidence. Identity and chromatographic purity answer different questions; one cannot stand in for the other.
Connect the product name, variant, lot identifier, report date, and issuing laboratory. A report is useful only when its sample can be linked to the material being reviewed.
Every Thymalin lot is analyzed by Nordicstar Analytical Sciences for identity, content, and purity by HPLC with LC-MS confirmation. Each certificate carries a report number and verification key that can be checked at nordicstarlabs.com/verify. Research references below describe published science, not a certificate for a vial.
Read a COA with confidence| Presentation | Lot | HPLC purity | Tested | Certificate |
|---|---|---|---|---|
| 10 MG Current lot | GLZ-26-THYM-1064 | 99.659% | 19 Sep 2026 | NS-2026-06065 |
| 10 MG | GLZ-26-THYM-736 | 99.640% | 19 Aug 2026 | NS-2026-06201 |
| 10 MG | GLZ-26-THYM-636 | 99.754% | 06 Jul 2026 | NS-2026-06202 |
05 / Storage & handling
Keep sealed research material protected from moisture, unnecessary light and temperature fluctuations. Use the storage conditions documented for the specific compound, formulation and lot.
Solution stability depends on solvent, concentration, container and experimental conditions. Use a validated laboratory protocol; a universal post-reconstitution shelf life is not established by the literature summaries.
Explore the handling guide06 / Common questions
No. Thymalin is described in the scientific literature as a thymus-derived polypeptide preparation, while Thymulin is a distinct defined thymic peptide. The names should not be treated as interchangeable.
Thymalin is a multi-component thymus-derived polypeptide preparation. Published research reports that the dipeptide Glu-Trp (EW) was isolated from Thymalin, and the synthetic Glu-Trp preparation Thymogen was subsequently developed from this research. They should not be treated as interchangeable product identities.
Published research describes Thymalin as a complex containing multiple peptide components rather than one defined peptide molecule. Assigning one sequence or molecular weight to the entire complex would therefore be misleading without product-specific compositional documentation.
07 / Further reading
Selected literature for context. Read each study’s methods, experimental model, and limitations alongside its findings.
Curated pairings
